Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Posted June 6, 2008
Feds Finally Publish a Strategic Plan for Widespread Health IT Adoption
Analysis of: ONC-Coordinated Strategic Plan Released Setting Health IT Milestones Across Federal Agencies | www.hhs.gov
Author: GLG Member Program Contributor
The federal government, through its HHS Office of the National Coordinator for Health Information Technology (ONC), has finally published its much anticipated (and delayed) strategic plan for spreading health IT throughout the country.  The feds are still trying to reach the increasingly more elusive...
Posted June 6, 2008
A Big Win for Glaxo
Analysis of: GlaxoSmithKline given OK to sell bird-flu vaccine in Europe | www.bizjournals.com
Author: GLG Member Program Contributor
Whether or not the bird flu ever becomes a threat to humans, Glaxo has won here. Since it will be impossible to rule out a serious risk of epidemics, an effective vaccine will have to be purchased and stockpiled by governments and other health care systems.
Adam Fein Posted June 5, 2008
CA Sets More Realistic Pedigree Deadline, but Timeline Still Uncertain
Analysis of: Legislation seeks to ensure safety of all prescription drugs | dist26.casen.govoffice.com
Author: Adam Fein, Founder & President Pembroke Consulting Inc
California State Senator Ridley-Thomas has proposed further extensions of the deadline for serialization for pharmaceutical manufacturers.  I’m encouraged that California will be incorporating more realistic timelines for serialization, especially given the unknown prospects for national standards....
Adam Schaffner Posted June 3, 2008
Don't Get Sick After Hours: The Crisis to Improve Patient Care
Analysis of: Like Night and Day--Shedding Light on Off-Hours Care | content.nejm.org
Author: Adam Schaffner, Plastic and Reconstructive Surgeon The Detroit Medical Center
On nights, weekends, and holidays, senior healthcare professionals are rarely found in the hospital.  Problems arise from (1) too few qualified personnel available to address the needs of patients, (2) inability to obtain physician coverage for some specialties, and (3) inability to obtain and/or...
Adam Fein Posted June 2, 2008
NABP Exposes Fake Candian Online Pharmacies
Analysis of:  NABP Names 79 Internet Drug Outlets Operating in Conflict With Patient Safety and Pharmacy Practice Standards | news.yahoo.com
Author: Adam Fein, Founder & President Pembroke Consulting Inc
The National Association of Boards of Pharmacy (NABP) named 79 online pharmacies that are not safe for patients. Rather than a general “watch out” message, the NABP actually listed the web addresses for these rogue sources.  Many sites falsely claim to be “Canadian” pharmacies.  This was an...
Posted June 2, 2008
Big opportunity for Glaxo
Analysis of: GlaxoSmithKline given OK to sell bird-flu vaccine in Europe | www.bizjournals.com
Author: GLG Member Program Contributor
-Glaxo's pre-pandemic flu vaccine is a double opportunity - a chance to contract now with multiple governments to supply a pre-pandemic vaccine as well as a natural segue to become their future supplier of actual pandemic flu vaccine (when developed).  -When pandemic flu hits, the race will be...
Posted June 2, 2008
Chinese generics: Low prices bu qulaity reputation will favor India
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
China, buoyed by its recent economic boom, is invading industrilaized nation markets with many generic compounds , from pain killers to AIDS drugs. Chinese drugs are cheap, but have reputation for poor quality , especially with recent heparin fiasco. India has had a good track record with generics and...
Posted May 30, 2008
CMS Raises the Kimono on Medicare Part D Claims to Improve Patient Safety
Analysis of: Part D Claims Data to be used in Patient-Safety Initiatives | www.modernhealthcare.com
Author: GLG Member Program Contributor
The Center for Medicare and Medicaid Services (CMS), the financier for the Medicare and Medicaid Programs, has decided in final regulations to permit access of its vast and rapidly growing Part D data stores to the Food and Drug Administration , other government agencies and academic researchers to...
Posted May 27, 2008
Do not forget the cost of supplying from China
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
With the recent scandals around quality, one needs to look at China's government stepping in and improving the quality. Expect additional testing requirements and regulatory requirements consider the added cost of companies sending QA teams into China to support their development
Posted May 27, 2008
China-not your low cost center any longer
Analysis of: China Muscles In On The Generics Industry | www.pharmalot.com
Author: GLG Member Program Contributor
Cost of goods in China are increasing dramatically over the last few years The cost of compliance has and will increase dramatically as well. The internal regulatory costs for compliance has increased as well. Working with China is not cheap and we should look at China more as a part of a strategic...
Previous Page : 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Next191 to 200 of 649

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T05:45:18.353